中文

U.S. Stocks · Health Care · Free Data Page

NEUROCRINE BIOSCIENCES INC NBIX

NEUROCRINE BIOSCIENCES INC: FY2025 revenue $2.86B (+21.40% YoY); net income $478.6M; 0 alerts, 1 watch item out of 17 risk checks.
Close Price$168.86Day +2.57%Market Cap$17.09BP/E35.7xFY2025 earningsP/B5.25xROE (FY2025)16.4%Avg. equity

Prices are closing data as of 2026-11-09, not real-time quotes. Metric definitions: P/E, P/B, ROE.

Want the full AI research report for NEUROCRINE BIOSCIENCES INC?

This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.

New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.

10-Year FinancialsFY2016–2025

Key Multi-Year Facts

  • Revenue moved from $15.0M in FY2016 to $2.86B in FY2025 (9-year CAGR +79.2%).
  • Net income was negative in FY2016, FY2017.

Latest 5 Fiscal Years

Fiscal Year20212022202320242025
Revenue (USD B)1.131.491.892.362.86
YoY8.4%31.3%26.8%24.8%21.4%
Net Income (USD B)0.090.150.250.340.48
YoY-78.0%72.4%61.6%36.7%40.2%
Operating Cash Flow (USD B)0.260.340.390.600.78
ROE7.2%10.0%12.7%14.2%16.4%
Gross Margin98.7%98.4%97.9%98.6%98.2%
Net Margin7.9%10.4%13.2%14.5%16.7%
Debt-to-Assets33.7%27.9%31.4%30.4%29.8%
Show all 10 fiscal years
Fiscal Year2016201720182019202020212022202320242025
Revenue (USD B)0.010.160.450.791.051.131.491.892.362.86
YoY—977.5%179.2%74.7%32.7%8.4%31.3%26.8%24.8%21.4%
Net Income (USD B)-0.14-0.140.020.040.410.090.150.250.340.48
YoY———75.4%1000.8%-78.0%72.4%61.6%36.7%40.2%
Operating Cash Flow (USD B)-0.11-0.090.100.150.230.260.340.390.600.78
ROE-44.8%-41.5%4.9%6.6%46.2%7.2%10.0%12.7%14.2%16.4%
Gross Margin100.0%99.2%98.9%—99.0%98.7%98.4%97.9%98.6%98.2%
Net Margin-940.6%-88.2%4.7%4.7%38.9%7.9%10.4%13.2%14.5%16.7%
Debt-to-Assets13.8%54.5%51.6%51.2%35.1%33.7%27.9%31.4%30.4%29.8%

Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: SEC XBRL filings, compiled mechanically without AI. Official filings

Risk ChecklistAs of 2026-11-10

Rules-based screening using SEC XBRL financial data and 8-K/NT material event filings (no AI opinions).

0Alert 1Watch 13Pass 3N/A

Items Flagged for Review

  • Watch

    GoodwillFinancial Quality

    $0.50B, 12.9% of equity

    Quarterly (2026-09-30) · What is this?

An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.

More U.S. data: 500 largest U.S. companies · U.S. high dividend stocks · Is the stock market open today?

Compiled mechanically from public filings and market quotes (data as of 2026-11-10). For informational purposes only, not investment advice.